As of March 2026 Relmada Therapeutics has a market cap of โน64.75 Billion. This makes Relmada Therapeutics the world's 6588th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 25th, 2026 the market cap of Relmada Therapeutics was reported to be: